Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

18 trials with published results (16%)

Research Maturity

69 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.6%

4 terminated out of 112 trials

Success Rate

94.5%

+8.0% vs benchmark

Late-Stage Pipeline

13%

14 trials in Phase 3/4

Results Transparency

26%

18 of 69 completed with results

Key Signals

18 with results95% success

Data Visualizations

Phase Distribution

95Total
Not Applicable (72)
P 1 (1)
P 2 (8)
P 3 (2)
P 4 (12)

Trial Status

Completed69
Unknown17
Recruiting10
Terminated4
Active Not Recruiting4
Withdrawn3

Trial Success Rate

94.5%

Benchmark: 86.5%

Based on 69 completed trials

Clinical Trials (112)

Showing 20 of 20 trials
NCT07522918Not ApplicableCompleted

Single-Session Extraoral PBM After Third Molar Extraction

NCT03404895Not ApplicableWithdrawn

The Mount Sinai Diabetic Foot Ulcer Prospective Trial

NCT02876107Phase 2Active Not Recruiting

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

NCT07033039Not ApplicableRecruiting

Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre

NCT06995144Phase 4Completed

Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure

NCT07442344Not ApplicableNot Yet RecruitingPrimary

Care Bundle for Prevention of Skin Complications and Edema in Restrained Patients

NCT07418814Not ApplicableNot Yet Recruiting

Infant Massage for Lymphedema and Comfort in Preterm Newborns

NCT02411656Phase 2Active Not RecruitingPrimary

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

NCT04691700Phase 4Active Not Recruiting

GOREISAN for Heart Failure (GOREISAN-HF) Trial

NCT05505500Recruiting

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

NCT05628688Completed

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Insight® Pro Device for Evaluating Lymphatic and Venous Disorders (VOLGA)

NCT06483204Phase 4WithdrawnPrimary

Steroids for Rhinoplasty: Pain, Nausea, Edema and Ecchymosis

NCT04759274Not ApplicableRecruitingPrimary

Diuretic Tuner Clinical Decision Support

NCT06011798Phase 2Completed

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

NCT06069908Not ApplicableCompleted

Transcutaneous Auricular Vagus Nerve Stimulation in Upper Extremity Lymphedema

NCT07062757Not ApplicableEnrolling By Invitation

Lymphatic Drainage Massage and Melatonin in Post-Orthognathic Surgery Pain and Edema

NCT05142800Active Not Recruiting

Screening For BCRL In Targeted Therapy For Breast Cancer

NCT06938048Not ApplicableEnrolling By InvitationPrimary

COMPARISON OF BANDAGE IN HAND EDEMA

NCT03213717Not ApplicableCompleted

Effect of Body Weight Loading on Urinary Electrolyte Excretion

NCT04278404Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Scroll to load more

Research Network

Activity Timeline